Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synthetic Biologics Inc (NYSE MKT LLC:SYN)

1.61
Delayed Data
As of Aug 26
 0.00 / 0.00%
Today’s Change
0.93
Today|||52-Week Range
3.44
-29.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2011
Quarter 4
2011
Quarter 1
2012
Quarter 2
2016
Revenue and IncomeNet Revenues293.4K0.000.000.00
 
 
Cost of Goods Sold525.2K1.7M0.000.00
 
 
 
Depreciation And Amortization24.7K11.0K20.0K20.0K
 
 
 
 
 
 
Operating ExpensesGross Income-256.4K-1.7M-20.0K-20.0K
 
 
 
 
 
General Expenses681.8K--1.8M9.3M
 
 
 
 
Other Operating Expenses0.00911.0K0.000.00
 
 
Research And Development0.000.00386.0K7.2M
 
 
 
Total Operating Expenses1.2M2.6M1.9M9.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-938.2K-2.6M-1.9M-9.3M
 
 
 
 
 
Extraordinary Credit0.00--0.003.5M
 
 
Extraordinary Charge-165.0K--0.000.00
 
 
Other Expenses5.2K-18.0K5.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.1M-2.7M-1.8M-5.8M
 
 
 
 
 
Minority Interest0.000.000.00-82.0K
 
 
Discontinued Operations0.00-523.0K0.000.00
 
 
Extraordinary Items0.000.00677.0K0.00
 
 
Net Income-1.1M-3.2M-1.9M-5.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS28.1M27.7M32.0M91.0M
 
 
 
 
 
Shares To Calculate EPS Diluted28.1M27.7M32.0M93.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.04---$0.04-$0.10
 
 
 
 
EPS Diluted-$0.04-$0.11-$0.06-$0.10